Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69,110,956
-
Total 13F shares
-
1,829,647
-
Share change
-
+299,193
-
Total reported value
-
$43,174,696
-
Put/Call ratio
-
414%
-
Price per share
-
$23.60
-
Number of holders
-
48
-
Value change
-
+$7,591,789
-
Number of buys
-
25
-
Number of sells
-
15
Institutional Holders of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) as of Q4 2017
As of 31 Dec 2017,
PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,829,647 shares.
The largest 10 holders included
BlackRock Inc., CITADEL ADVISORS LLC, Vanguard Group Inc, STATE STREET CORP, NORTHERN TRUST CORP, WELLS FARGO & COMPANY/MN, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, AQR CAPITAL MANAGEMENT LLC, and MORGAN STANLEY.
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.